3 documents found, page 1 of 1
Risk Factors for Mortality in Hemodialysis Patients: Two-Year Follow-Up Study
Sameiro Faria, M; Ribeiro, S; Costa, E; Mendonça, D; Teixeira, L; Rocha-Pereira, P; Fernandes, J; Nascimento, H; Kohlova, M; Reis, F; Amado, LBackground. End-stage renal disease (ESRD) patients under hemodialysis (HD) have high mortality rate. Inflammation, dyslipidemia, disturbances in erythropoiesis, iron metabolism, endothelial function, and nutritional status have been reported in these patients. Our aim was to identify any significant association of death with these disturbances, by performing a two-year follow-up study. Methods and Results. A l...
Von Recklinghausen neurofibromatosis and malignant pheochromocytoma: presentati...
Ventura, A; Ribeiro, J; Murinello, A; Amado, L; Morgado, A; Guerra, C; Murinello, F; Silva, J L; Mota, J ANeurofibromatosis may involve every organ. Manifestations vary greatly and different kind of neoplasia may be associated with excessive frequency; it's the case of pheochromocytoma that, as a benign tumor, coexists in 10%. Description of coexistency as a malignant tumor is a rarity; therefore, we think it's interesting to publish our experience. Nevertheless the association of Von Recklinghausen's disease with ...
Neurofibromatose de Von Recklinghausen e Feocromocitoma Maligno: Apresentação d...
Ventura, A; Ribeiro, J; Murinello, A; Amado, L; Morgado, A; Guerra, C; Murinello, F; Silva, JL; Mota, JAA neurofibromatose é uma doença que pode afectar todos os órgãos. As suas manifestações clínicas podem ser muito variáveis e associam-se-lhe, frequentemente, neoplasias. é o caso do feocromositoma, que na sua forma benigna, coexiste em 10 % dos casos; contudo, a descrição da associação com a forma maligna é uma raridade, o que justifica o interesse da divulgação da nossa experiência. Salientamos, no entanto, qu...